Database of bioactive ring systems with calculated properties and its use in bioisosteric design and scaffold hopping.
暂无分享,去创建一个
[1] David R. Langley,et al. MORPH: A New Tool for Ligand Design , 2010, J. Chem. Inf. Model..
[2] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[3] P Ertl,et al. World Wide Web-based system for the calculation of substituent parameters and substituent similarity searches. , 1998, Journal of molecular graphics & modelling.
[4] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[5] Peter Ertl,et al. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions , 2009, J. Cheminformatics.
[6] Gordon M. Crippen,et al. Prediction of Physicochemical Parameters by Atomic Contributions , 1999, J. Chem. Inf. Comput. Sci..
[7] Peter Ertl,et al. Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization , 2010, Molecular informatics.
[8] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[9] Matthias Rarey,et al. Recore: A Fast and Versatile Method for Scaffold Hopping Based on Small Molecule Crystal Structure Conformations , 2007, J. Chem. Inf. Model..
[10] Peter Ertl,et al. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds. , 2006, Journal of medicinal chemistry.
[11] John P. Overington,et al. Probing the links between in vitro potency, ADMET and physicochemical parameters , 2011, Nature Reviews Drug Discovery.
[12] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[13] Peter Ertl,et al. Molecular structure input on the web , 2010, J. Cheminformatics.
[14] Paul A. Bartlett,et al. CAVEAT: A program to facilitate the design of organic molecules , 1994, J. Comput. Aided Mol. Des..
[15] Gavin Harper,et al. Drug rings database with web interface. A tool for identifying alternative chemical rings in lead discovery programs. , 2003, Journal of medicinal chemistry.
[16] Stefan Wetzel,et al. The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..
[17] Peter Ertl,et al. Simple Quantum Chemical Parameters as an Alternative to the Hammett Sigma Constants in QSAR Studies , 1997 .
[18] Anne Mai Wassermann,et al. SARANEA: A Freely Available Program To Mine Structure-Activity and Structure-Selectivity Relationship Information in Compound Data Sets , 2010, J. Chem. Inf. Model..
[19] Anna Linusson,et al. SHOP: scaffold HOPping by GRID-based similarity searches. , 2007, Journal of medicinal chemistry.
[20] G. Hessler,et al. The scaffold hopping potential of pharmacophores. , 2010, Drug discovery today. Technologies.
[21] P. Selzer,et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.
[22] Jürgen Bajorath,et al. Lessons Learned from Molecular Scaffold Analysis , 2011, J. Chem. Inf. Model..
[23] Ian A. Watson,et al. Selection of heterocycles for drug design. , 2004, Journal of molecular graphics & modelling.
[24] Peter Ertl,et al. Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups , 2003, J. Chem. Inf. Comput. Sci..
[25] Sarah R. Langdon,et al. Scaffold Diversity of Exemplified Medicinal Chemistry Space , 2011, J. Chem. Inf. Model..